What is the current HIV Diagnosis market size?

The HIV Diagnosis market size is approximately USD 2.5 billion as of 2023.

What is the expected growth forecast for the HIV Diagnosis market?

The market is expected to grow at a CAGR of 6.2% from 2023 to 2028.

What are the key drivers of the HIV Diagnosis market?

Increasing awareness and government initiatives are key drivers of the HIV Diagnosis market.

What are the major challenges facing the HIV Diagnosis market?

Stigma and lack of access to healthcare are major challenges facing the HIV Diagnosis market.

Which regions are leading the HIV Diagnosis market?

North America and Europe are leading the HIV Diagnosis market due to high awareness.

Who are the top companies in the HIV Diagnosis market?

Top companies include Roche and Abbott, offering innovative diagnostic solutions.

What are the future opportunities in the HIV Diagnosis market?

Point-of-care testing and home-based testing are future opportunities in the HIV Diagnosis market.

How is technology impacting the HIV Diagnosis market?

Advances in technology are improving test accuracy and speed in the HIV Diagnosis market.

What is the current regulatory landscape for the HIV Diagnosis market?

Regulatory bodies are implementing strict guidelines for HIV Diagnosis market products.

What is the future outlook for the HIV Diagnosis market?

The future outlook is positive, with increasing demand for diagnostic tests.

HIV Diagnosis Growth Analysis & Future Outlook 2033

HIV Diagnosis by Application (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, Others), by Types (Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, Tests for Viral Identification), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $12345.67 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $12345.67 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

HIV Diagnosis Market Size | CAGR 10.2 Forecast 2033

HIV Diagnosis Growth Analysis & Future Outlook 2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $12345.67 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $12345.67 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

HIV Diagnosis Market Overview

The HIV Diagnosis market is a crucial segment of the healthcare industry, focused on the development and implementation of diagnostic solutions for Human Immunodeficiency Virus (HIV). As the world grapples with the ongoing pandemic, the HIV Diagnosis market size is estimated to be approximately $3.5 billion. The growth outlook for this market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of around 8.5% during the forecast period. This industry expansion is driven by advancements in diagnostic technologies, increasing awareness about HIV, and government initiatives to enhance healthcare infrastructure. The scope of this market encompasses various diagnostic methods, including nucleic acid tests, serological tests, and rapid tests, catering to diverse end-users such as hospitals, clinics, and research institutions.

Loading chart…

Key forces shaping the HIV Diagnosis industry include technology shifts towards more accurate and rapid diagnostic methods, regulatory requirements for enhanced safety and efficacy, and changing consumer behavior with increased awareness and demand for early diagnosis. The largest region in the HIV Diagnosis market is North America, while the fastest-growing region is anticipated to be Asia-Pacific, driven by expanding healthcare infrastructure and growing awareness about HIV. As the market continues to evolve, it is essential for stakeholders to stay informed about the latest developments and trends to capitalize on emerging opportunities and navigate challenges effectively.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	26.85 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Siemens Healthineers; Roche Diagnostics; Abbott Laboratories; Beckman Coulter; Thermo Fisher Scientific; Merck & Co., Inc.; Becton, Dickinson and Company; Hologic, Inc.; Abbott; Bio-Rad Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The HIV Diagnosis market is poised for significant growth, driven by evolving technologies, shifting disease landscapes, and changing regulatory environments. Understanding the dynamics of this market is crucial for stakeholders to navigate its complexities and capitalize on emerging opportunities.

Growth Drivers2 items

Advancements in diagnostic technologies, such as point-of-care testing and molecular diagnostics, are enhancing the accuracy and speed of HIV Diagnosis, thereby contributing to the growth of the HIV Diagnosis market size.

Increasing awareness and growth forecast for early detection and treatment are driving the demand for HIV diagnosis, especially in regions with high prevalence rates, influencing the overall HIV Diagnosis market.

Restraints2 items

High costs associated with advanced diagnostic tests and technologies can limit access to HIV Diagnosis, particularly in low- and middle-income countries, affecting the HIV Diagnosis market size.

Stringent regulatory frameworks and the need for approvals can slow down the introduction of new diagnostic solutions, impacting the growth forecast of the HIV Diagnosis market.

Opportunities2 items

The integration of artificial intelligence and data analytics in HIV diagnosis presents opportunities for more precise and personalized medicine approaches, potentially boosting the HIV Diagnosis market.

Partnerships between diagnostic companies, research institutions, and healthcare providers can accelerate the development and dissemination of innovative HIV Diagnosis technologies, contributing to the growth forecast.

Challenges2 items

Ensuring the accessibility and affordability of HIV Diagnosis technologies in resource-limited settings remains a significant challenge, affecting the HIV Diagnosis market size and equity in healthcare delivery.

The HIV Diagnosis market must address the issue of stigma associated with HIV, which can deter individuals from seeking diagnosis and treatment, thereby impacting the overall effectiveness of diagnosis efforts and the growth forecast.

Market Segmentation

Loading chart…

The HIV Diagnosis market can be segmented based on Application, which refers to the different uses of HIV diagnosis products and services. This segmentation category contributes to the overall HIV Diagnosis market size by highlighting the various areas where these products and services are utilized. The main applications of HIV diagnosis include blood screening, disease diagnosis, and research purposes. Understanding the HIV Diagnosis segmentation by application helps in identifying the most significant areas of demand and revenue generation.

Another crucial segmentation category in the HIV Diagnosis market is Types, which comprises subtypes such as nucleic acid tests, antibody tests, and antigen/antibody combination tests. Each subtype has its unique characteristics, advantages, and limitations, contributing to the overall market size. The Types segmentation provides insights into the different technologies and methods employed for HIV diagnosis, enabling market players to focus on the most promising and in-demand technologies. By analyzing the market taxonomy, including HIV Diagnosis segmentation, researchers can better comprehend the complexities of the market and make informed decisions.

HIV Diagnosis Segmentation Breakdown12 items

Application

Diagnostic Laboratories

Hospitals

Blood Banks

Home Care Settings

Others

Types

Antibody Tests

Viral Load Tests

CD4 Tests

Tests for Early Infant Diagnosis

Tests for Viral Identification

Regional Insights

Loading chart…

The HIV Diagnosis market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced diagnostic technologies, government policies supporting HIV awareness, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - ecosystem maturity, high adoption rates, and significant investments in research and development; Europe - policies supporting HIV prevention, demographics with high risk groups, and established infrastructure; Asia Pacific - growing awareness, increasing adoption of diagnostic technologies, and expanding infrastructure; Latin America - government initiatives, rising awareness, and improving infrastructure; Middle East & Africa - growing demand, increasing investment in healthcare, and expanding access to diagnostic services.

The regional forecast indicates a significant opportunity for growth in the HIV Diagnosis market, driven by increasing demand for diagnostic services, advancements in technology, and supportive government policies. Understanding the regional dynamics and key drivers is crucial for stakeholders to develop effective strategies and capitalize on the growing HIV Diagnosis market.

Competitive Landscape

The HIV Diagnosis market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The HIV Diagnosis competitive landscape is characterized by high competition, with key players vying for market share through various strategies. Global players such as Roche Diagnostics and Abbott Laboratories have a significant presence, while local companies focus on regional strengths and partnerships.

Companies in the HIV Diagnosis market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting to these challenges by focusing on strategic initiatives such as regional expansion, innovation pipeline, and local manufacturing.

Siemens Healthineers: regional expansion

Roche Diagnostics: premium pricing

Abbott Laboratories: innovation pipeline

Beckman Coulter: OEM tie-ups

Thermo Fisher Scientific: vertical integration

Merck & Co., Inc.: local manufacturing

Key HIV Diagnosis Companies10 items

Siemens Healthineers

Roche Diagnostics

Abbott Laboratories

Beckman Coulter

Thermo Fisher Scientific

Merck & Co., Inc.

Becton, Dickinson and Company

Hologic, Inc.

Abbott

Bio-Rad Laboratories

Market Ecosystem

The HIV Diagnosis ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main components: upstream, midstream, and downstream. Upstream participants, such as technology providers and suppliers, create and supply the foundational elements, including diagnostic kits and testing equipment. Midstream participants, comprising integrators and channels, facilitate the distribution and integration of these elements. Downstream participants, including end users such as healthcare providers and patients, ultimately capture the value created by the ecosystem through the diagnosis and treatment of HIV.

Raw material/component suppliers — provide diagnostic kit components

Technology providers — develop diagnostic technologies

OEMs / manufacturers — produce diagnostic equipment

Distributors / channel partners — distribute diagnostic products

Service providers / after-sales — offer maintenance and support services

End users / buyers — healthcare providers and patients

Regulators/standards bodies — establish diagnostic standards and guidelines

In the HIV Diagnosis ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through the establishment of diagnostic standards and guidelines. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact the supply chain. Switching costs and partnerships also play a crucial role, as end users may face significant costs when switching between different diagnostic technologies or platforms. Furthermore, the ecosystem differs by region, with varying regulatory frameworks and standards influencing the value chain analysis and the overall HIV Diagnosis ecosystem.

Recent Industry Insights

The HIV Diagnosis industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships, such as the collaboration between major pharmaceutical companies and research institutions, have been formed to accelerate the development of innovative diagnostic solutions. Furthermore, there have been strategic mergers and acquisitions, including the acquisition of specialized diagnostic companies by leading industry players.

Recent product launches, such as point-of-care testing kits and next-generation sequencing technologies, have improved the accuracy and accessibility of HIV diagnosis. Additionally, regulatory changes, including the approval of new diagnostic assays by government agencies, have expanded the range of available diagnostic options. These developments have contributed to a shift in consumer and enterprise trends, with a growing emphasis on early detection and personalized medicine.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the HIV Diagnosis market outlook. The market attractiveness is moderate, driven by increasing awareness and advancements in diagnostic technologies. Competitive intensity is high, with key players investing heavily in research and development. The long-term outlook is positive, with growing demand for early diagnosis and treatment. The innovation landscape is evolving, with a focus on point-of-care diagnostics and molecular testing. However, the demand-supply balance is a concern, with limited access to diagnostic facilities in some regions. Key risk factors include regulatory changes and supply chain disruptions.

11 items

1. Executive Summary

2. HIV Diagnosis Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global HIV Diagnosis Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global HIV Diagnosis Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Diagnostic Laboratories

6.1.2. Hospitals

6.1.3. Blood Banks

6.1.4. Home Care Settings

6.1.5. Others

6.2. Global HIV Diagnosis Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Antibody Tests

6.2.2. Viral Load Tests

6.2.3. CD4 Tests

6.2.4. Tests for Early Infant Diagnosis

6.2.5. Tests for Viral Identification

6.3. Global HIV Diagnosis Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global HIV Diagnosis Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global HIV Diagnosis Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global HIV Diagnosis Market Competition by Key Manufacturers

8.1. Global HIV Diagnosis Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global HIV Diagnosis: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Siemens Healthineers

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Roche Diagnostics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Abbott Laboratories

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Beckman Coulter

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Thermo Fisher Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Merck & Co., Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Becton, Dickinson and Company

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Hologic, Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Abbott

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Bio-Rad Laboratories

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global HIV Diagnosis Market

Figure 4: Global HIV Diagnosis Market: Drivers

Figure 5: Global HIV Diagnosis Market: Challenges

Figure 6: Global HIV Diagnosis Market: Trends

Figure 7: Global HIV Diagnosis Market: Opportunity

Figure 8: Global HIV Diagnosis Market: Restraint

Figure 9: Global HIV Diagnosis Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global HIV Diagnosis Market Value (USD Million) By Region

Figure 15: Global HIV Diagnosis Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global HIV Diagnosis Market Value (USD Million) By Region

Figure 23: Global HIV Diagnosis Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global HIV Diagnosis Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global HIV Diagnosis Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global HIV Diagnosis Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global HIV Diagnosis Market Value (USD Million) By Region

Table 10: Global HIV Diagnosis Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global HIV Diagnosis Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global HIV Diagnosis Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global HIV Diagnosis Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Siemens Healthineers Basic Information And Sales Area

Table 31: Siemens Healthineers. Products Portfolio

Table 32: Roche Diagnostics Basic Information And Sales Area

Table 33: Roche Diagnostics. Products Portfolio

Table 34: Abbott Laboratories Basic Information And Sales Area

Table 35: Abbott Laboratories. Products Portfolio

Table 36: Beckman Coulter Basic Information And Sales Area

Table 37: Beckman Coulter. Products Portfolio

Table 38: Thermo Fisher Scientific Basic Information And Sales Area

Table 39: Thermo Fisher Scientific. Products Portfolio

Table 40: Merck & Co., Inc. Basic Information And Sales Area

Table 41: Merck & Co., Inc.. Products Portfolio

Table 42: Becton, Dickinson and Company Basic Information And Sales Area

Table 43: Becton, Dickinson and Company. Products Portfolio

Table 44: Hologic, Inc. Basic Information And Sales Area

Table 45: Hologic, Inc.. Products Portfolio

Table 46: Abbott Basic Information And Sales Area

Table 47: Abbott. Products Portfolio

Table 48: Bio-Rad Laboratories Basic Information And Sales Area

Table 49: Bio-Rad Laboratories. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global HIV Diagnosis Market Value (USD Million) By Region

Table 55: Global HIV Diagnosis Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

HIV Diagnosis Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	26.85 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Siemens Healthineers; Roche Diagnostics; Abbott Laboratories; Beckman Coulter; Thermo Fisher Scientific; Merck & Co., Inc.; Becton, Dickinson and Company; Hologic, Inc.; Abbott; Bio-Rad Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options